Torthaí cuardaigh - Gail J. Roboz

Beachtaigh na torthaí
  1. 1
    Novel Approaches to the Treatment of Acute Myeloid Leukemia

    Novel Approaches to the Treatment of Acute Myeloid Leukemia de réir Gail J. Roboz

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Acute myeloid leukemia stem cells: seek and destroy

    Acute myeloid leukemia stem cells: seek and destroy de réir Gail J. Roboz, Mónica L. Guzmán

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis

    Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis de réir Gail J. Roboz, Sérgio Dias, George Lam, William J. Lane, Steven L. Soignet, Raymond P. Warrell, Shahin Rafii

    Foilsithe / Cruthaithe 2000
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    The BiTE (bispecific T‐cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types

    The BiTE (bispecific T‐cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types de réir Hermann Einsele, Hossein Borghaei, Robert Z. Orlowski, Marion Subklewe, Gail J. Roboz, Gerhard Zugmaier, Peter Kufer, Karim Iskander, Hagop M. Kantarjian

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Prevalence, Management, and Clinical Consequences of QT Interval Prolongation During Treatment With Arsenic Trioxide

    Prevalence, Management, and Clinical Consequences of QT Interval Prolongation During Treatment With Arsenic Trioxide de réir Gail J. Roboz, Ellen K. Ritchie, Rebecca F. Carlin, Michael S. Samuel, Leanne Gale, Juliette L. Provenzano-Gober, Tania J. Curcio, Eric J. Feldman, Paul Kligfield

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia

    Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia de réir Ellen K. Ritchie, Eric J. Feldman, Paul J. Christos, Sarah D. Rohan, Catherine B. Lagassa, Cindy Ippoliti, Joseph M. Scandura, Karen-Sue Carlson, Gail J. Roboz

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    The effect of initial molecular profile on response to recombinant interferon‐α (rIFNα) treatment in early myelofibrosis

    The effect of initial molecular profile on response to recombinant interferon‐α (rIFNα) treatment in early myelofibrosis de réir Richard T. Silver, Ariella Barel, Elena Lascu, Ellen K. Ritchie, Gail J. Roboz, Paul J. Christos, Attilio Orazi, Duane C. Hassane, Wayne Tam, Nicholas C.P. Cross

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    TP53 Mutations Predict Poorer Responses to CPX-351 in Acute Myeloid Leukemia

    TP53 Mutations Predict Poorer Responses to CPX-351 in Acute Myeloid Leukemia de réir Aaron D. Goldberg, Chetasi Talati, Pinkal Desai, Christopher Famulare, Sean M. Devlin, Noushin Farnoud, David A. Sallman, Jeffrey E. Lancet, Gail J. Roboz, Kendra Sweet, Martin S. Tallman

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response

    A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response de réir Keith W. Pratz, Jorge E. Cortés, Gail J. Roboz, Niranjan Rao, Omotayo Arowojolu, Adam Stine, Yukimasa Shiotsu, Aiko Shudo, Shiro Akinaga, Donald Small, Judith E. Karp, Mark J. Levis

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche

    In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche de réir Hong Zong, Siddhartha Sen, Guodong Zhang, Mu Chuanjie, Z F Albayati, David G. Gorenstein, Yang Liu, M. Ferrari, Peter A. Crooks, Gail J. Roboz, Haifa Shen, Mónica L. Guzmán

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels

    FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels de réir Vicenta Trujillo-Alonso, Edwin C. Pratt, Hongliang Zong, Andres Lara-Martinez, Charalambos Kaittanis, Mohamed O. Rabie, Valerie A. Longo, Michael W. Becker, Gail J. Roboz, Jan Grimm, Mónica L. Guzmán

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    A Chemical Biology Approach to the Chaperome in Cancer—HSP90 and Beyond

    A Chemical Biology Approach to the Chaperome in Cancer—HSP90 and Beyond de réir Tony Taldone, Tai Wang, Anna Rodina, Nagavarakishore Pillarsetty, Chander Singh Digwal, Sahil Sharma, Pengrong Yan, Suhasini Joshi, Piyusha P. Pagare, Alexander Bolaender, Gail J. Roboz, Mónica L. Guzmán, Gabriela Chiosis

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations

    Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations de réir Nuria Mencia-Trinchant, Yang Hu, Maria Antonina Alas, Fatima Bhopalwala Ali, Bas J. Wouters, Sang Min Lee, Ellen K. Ritchie, Pinkal Desai, Mónica L. Guzmán, Gail J. Roboz, Duane C. Hassane

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Somatic mutations precede acute myeloid leukemia years before diagnosis

    Somatic mutations precede acute myeloid leukemia years before diagnosis de réir Pinkal Desai, Nuria Mencia-Trinchant, Oleksandr Savenkov, Michael S. Simon, Gloria Cheang, Sang‐Min Lee, Michael Samuel, Ellen K. Ritchie, Mónica L. Guzmán, Karla V. Ballman, Gail J. Roboz, Duane C. Hassane

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

    First-In-Man Study of CPX-351: A Liposomal Carrier Containing Cytarabine and Daunorubicin in a Fixed 5:1 Molar Ratio for the Treatment of Relapsed and Refractory Acute Myeloid Leuk... de réir Eric J. Feldman, Jeffrey E. Lancet, Jonathan E. Kolitz, Ellen K. Ritchie, Gail J. Roboz, Alan F. List, Steven L. Allen, Ekatherine Asatiani, Lawrence D. Mayer, Christine E. Swenson, Arthur C. Louie

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m <i>IDH1</i> ) acute myeloid leukemia (AML)

    Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m <i>IDH1</i> ) acute myeloid leukemia (AML) de réir Jorge E. Cortés, Brian A. Jonas, Gary J. Schiller, Alice S. Mims, Gail J. Roboz, Andrew H. Wei, Pau Montesinos, P. Brent Ferrell, Karen Yee, Pierre Fenaux, Anthony P. Schwarer, Justin M. Watts

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML

    Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML de réir Joseph M. Scandura, Gail J. Roboz, Michelle Moh, Ewelina Morawa, Fabienne Brenet, Jahar R Bose, Luis Juárez Villegas, Usama Gergis, Sebastian Mayer, Cindy Ippoliti, Tania J. Curcio, Ellen K. Ritchie, Eric J. Feldman

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia

    Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia de réir Gail J. Roboz, Ellen K. Ritchie, Yulia Dault, Linda Lam, Danielle C. Marshall, Nicole M. Cruz, Hsiao-Ting Hsu, Duane C. Hassane, Paul J. Christos, Cindy Ippoliti, Joseph M. Scandura, Mónica L. Guzmán

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia

    Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia de réir Mónica L. Guzmán, Neng Yang, Krishan K. Sharma, Marlene Balys, Cheryl A. Corbett, Craig T. Jordan, Michael W. Becker, Ulrich Steidl, Omar Abdel‐Wahab, Ross L. Levine, Guido Marcucci, Gail J. Roboz, Duane C. Hassane

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia

    Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia de réir Mayumi Sugita, Román Galetto, Hongliang Zong, Nathan Ewing-Crystal, Vicenta Trujillo-Alonso, Nuria Mencia-Trinchant, Winnie Yip, Stéphanie Filipe, Céline Lebuhotel, Agnès Gouble, Duane C. Hassane, Julianne Smith, Gail J. Roboz, Mónica L. Guzmán

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: